Eligible members can access medical guidance and behavioral support under the same umbrella, improving coordination between medication and lifestyle changes
GHK-Cu continues to attract interest in the world of cosmetic skin care for its role as a copper peptide and its association with skin appearance research
Studies indicate that in the absence of appropriate medical intervention, approximately 20% of patients with diabetic wounds will require lower limb amputation, with a subsequent one-year mortality rate of 13% post-diagnosis 19,20
[1] These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Plus, coverage considerations and a first look at Scripta's GLP-1 Navigator
The weight-loss tirzepatide product Zepbound carries a separate FDA approval for chronic weight management